Clinical Trial Update: A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting

View source ↗

Summary

A real-world study evaluating acoramidis in patients with transthyretin amyloid cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Drugs mentioned

• Acoramidis (acoramidis)

Snippet

Sponsor: Bayer | Conditions: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | Status: RECRUITING